These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 23102376)

  • 1. Aberrations in translational regulation are associated with poor prognosis in hormone receptor-positive breast cancer.
    Meric-Bernstam F; Chen H; Akcakanat A; Do KA; Lluch A; Hennessy BT; Hortobagyi GN; Mills GB; Gonzalez-Angulo A
    Breast Cancer Res; 2012 Oct; 14(5):R138. PubMed ID: 23102376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of phosphorylated eIF4E-binding protein 1, but not of eIF4E itself, predicts survival in male breast cancer.
    Millican-Slater RA; Sayers CD; Hanby AM; Hughes TA
    Br J Cancer; 2016 Jul; 115(3):339-45. PubMed ID: 27280636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poor prognosis of single hormone receptor- positive breast cancer: similar outcome as triple-negative breast cancer.
    Bae SY; Kim S; Lee JH; Lee HC; Lee SK; Kil WH; Kim SW; Lee JE; Nam SJ
    BMC Cancer; 2015 Mar; 15():138. PubMed ID: 25880075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of programmed cell death 4 (PDCD4) is associated with aromatase inhibitor resistance and a poor prognosis in estrogen receptor-positive breast cancer.
    Chen Z; Yuan YC; Wang Y; Liu Z; Chan HJ; Chen S
    Breast Cancer Res Treat; 2015 Jul; 152(1):29-39. PubMed ID: 26026468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab.
    Kurebayashi J; Kanomata N; Yamashita T; Shimo T; Mizutoh A; Moriya T; Sonoo H
    Breast Cancer; 2015 May; 22(3):292-9. PubMed ID: 23749689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of mTOR/S6K But Not MAPK Pathways Might Be Associated With High Ki-67, ER(+), and HER2(-) Breast Cancer.
    Yanai A; Inoue N; Yagi T; Nishimukai A; Miyagawa Y; Murase K; Imamura M; Enomoto Y; Takatsuka Y; Watanabe T; Hirota S; Sasa M; Katagiri T; Miyoshi Y
    Clin Breast Cancer; 2015 Jun; 15(3):197-203. PubMed ID: 25600244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eukaryotic initiation factor 4E overexpression in triple-negative breast cancer predicts a worse outcome.
    Flowers A; Chu QD; Panu L; Meschonat C; Caldito G; Lowery-Nordberg M; Li BD
    Surgery; 2009 Aug; 146(2):220-6. PubMed ID: 19628077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of HER2 phosphorylation at tyrosine 1221/1222 improves prediction of poor survival for breast cancer patients with hormone receptor-positive tumors.
    Frogne T; Laenkholm AV; Lyng MB; Henriksen KL; Lykkesfeldt AE
    Breast Cancer Res; 2009; 11(1):R11. PubMed ID: 19239686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of the Activation Status of the Akt/mTOR Signalling Pathway on the Clinical Behaviour of Synovial Sarcoma: Retrospective Analysis of 174 Patients at a Single Institution.
    Li YX; Ding SS; Wen WJ; Han L; Wang HQ; Shi HY
    Cancer Manag Res; 2020; 12():1759-1769. PubMed ID: 32210617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of p70S6K1-mediated phosphorylation of eIF4B and PDCD4 proteins in the regulation of protein synthesis.
    Dennis MD; Jefferson LS; Kimball SR
    J Biol Chem; 2012 Dec; 287(51):42890-9. PubMed ID: 23105104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amplified in Breast Cancer Regulates Transcription and Translation in Breast Cancer Cells.
    Ochnik AM; Peterson MS; Avdulov SV; Oh AS; Bitterman PB; Yee D
    Neoplasia; 2016 Feb; 18(2):100-10. PubMed ID: 26936396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mTOR signaling pathway in penile squamous cell carcinoma: pmTOR and peIF4E over expression correlate with aggressive tumor behavior.
    Ferrandiz-Pulido C; Masferrer E; Toll A; Hernandez-Losa J; Mojal S; Pujol RM; Ramon y Cajal S; de Torres I; Garcia-Patos V
    J Urol; 2013 Dec; 190(6):2288-95. PubMed ID: 23764082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation between Ki-67, ER, PR, Her2/neu, p21, EGFR, and TOP II-α expression in invasive ductal breast cancer patients and correlations with prognosis.
    Yan J; Liu XL; Han LZ; Xiao G; Li NL; Deng YN; Yin LC; Ling LJ; Yu XY; Tan CL; Huang XP; Liu LX
    Asian Pac J Cancer Prev; 2015; 16(2):823-9. PubMed ID: 25684532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitosis-related phosphorylation of the eukaryotic translation suppressor 4E-BP1 and its interaction with eukaryotic translation initiation factor 4E (eIF4E).
    Sun R; Cheng E; Velásquez C; Chang Y; Moore PS
    J Biol Chem; 2019 Aug; 294(31):11840-11852. PubMed ID: 31201269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Prognostic Effect of Changes in Tumor Stage and Nodal Status After Neoadjuvant Chemotherapy in Each Primary Breast Cancer Subtype.
    Hayashi N; Takahashi Y; Matsuda N; Tsunoda H; Yoshida A; Suzuki K; Nakamura S; Yamauchi H
    Clin Breast Cancer; 2018 Apr; 18(2):e219-e229. PubMed ID: 29138067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of phosphorylated 4E-BP1 predicts for tumor recurrence and reduced survival in cervical carcinoma treated with postoperative radiotherapy.
    Benavente S; Vergés R; Hermosilla E; Fumanal V; Casanova N; García A; Ramón Y Cajal S; Giralt J
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1316-22. PubMed ID: 19362787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HPK1 positive expression associated with longer overall survival in patients with estrogen receptor-positive invasive ductal carcinoma‑not otherwise specified.
    Wang J; Song L; Yang S; Zhang W; Lu P; Li S; Li H; Wang L
    Mol Med Rep; 2017 Oct; 16(4):4634-4642. PubMed ID: 28765906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Difference in Prognostic Outcomes Between
    Yamamura J; Kamigaki S; Fujita J; Osato H; Komoike Y
    In Vivo; 2018; 32(2):353-358. PubMed ID: 29475920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact of the activation status of the Akt/mTOR pathway in synovial sarcoma.
    Setsu N; Kohashi K; Fushimi F; Endo M; Yamamoto H; Takahashi Y; Yamada Y; Ishii T; Yokoyama K; Iwamoto Y; Oda Y
    Cancer; 2013 Oct; 119(19):3504-13. PubMed ID: 23861137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of hormone receptor status on patterns of recurrence and clinical outcomes among patients with human epidermal growth factor-2-positive breast cancer in the National Comprehensive Cancer Network: a prospective cohort study.
    Vaz-Luis I; Ottesen RA; Hughes ME; Marcom PK; Moy B; Rugo HS; Theriault RL; Wilson J; Niland JC; Weeks JC; Lin NU
    Breast Cancer Res; 2012 Oct; 14(5):R129. PubMed ID: 23025714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.